Current Options for Improvement of Treatment of Gastroesophageal Reflux Disease
Journal Title: Гастроентерологія - Year 2014, Vol 2, Issue 52
Abstract
The article is dedicated to the treatment of one of the most common pathologies in gastroenterology — gastroesophageal reflux disease. The use of proton pump inhibitors and their combination with prokinetics is being dwelt.
Authors and Affiliations
S. M. Tkach
Diagnosis of Minimal Hepatic Encephalopathy Using Neuropsychometric Tests
Hepatic encephalopathy is threatening complication of both acute and chronic liver failure. Minimal hepatic encephalopathy is the initial stage of encephalopathy, has no neurological symptoms with the manifestation of co...
Morphofunctional State of Esophageal Mucosa in Patients with Gastroesophageal Reflux Disease Depending on the Nutritional Status of Patients
We have studied morphofunctional state of esophageal mucosa in 57 patients with gastroesophageal reflux disease (GERD) with normal (body mass index (BMI) — 18.5–24.9 kg/m2) and excessive (BMI over 25 kg/m2) body weight....
Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
Article deals with the use of proton pump inhibitors in gastroenterology. We considered the impact of proton pump inhibitors on of a variety of processes in the body, such as the absorption of vitamins and minerals, oste...
Clinical and laboratory features of pancreatic steatosis in children with overweight and obesity
Background. Nonalcoholic fatty pancreas disease is a pathological condition associated with obesity and components of the metabolic syndrome. Clinical features of the pancreatic steatosis can be caused by exocrine insuff...
Chronic inflammatory bowel diseases: epidemiological features in Ukraine
Background. The number of registered patients with inflammatory bowel diseases (IBD) that is characterized by systemic manifestations and polymorbidal course is increasing nowadays. IBD, which include ulcerative colitis...